NURECA
|
|
BOM : 543264     NSE : NURECA     | |
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive] Debt : High |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward Pledged Shares : NA |
May 25,2022 |
Price(EOD): ₹ 1,023.40
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Trading |
MCap: ₹ 1,023.40 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
NURECA | -4.1% | -23.9% | -31.6% |
ADANI TRANSMISSION | -7.8% | -19.9% | 51.1% |
ADANI ENTERPRISES | -1.8% | -9.3% | 64.3% |
SUNDRAM FASTENERS | 2.9% | -7.5% | 1.6% |
REDINGTON (INDIA) | -1% | -13.6% | 51.2% |
MMTC | -3.6% | -19.9% | -24.7% |
NOVARTIS INDIA | -3.2% | -8.7% | -7.6% |
MSTC | -3.4% | -19.4% | 6.4% |
SVP GLOBAL VENTURES | -1.2% | -26.7% | -49.4% |
FUNDAMENTAL ANALYSIS OF NURECA
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF NURECA
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
22.07
P/E Calculated based on EPS of 46.37
[ Mar2021 - Consolidated Results ] 6.27
P/B Calculated based on Book Value of 163.1
[ Mar2021 - Consolidated Results ] 4.15
P/S Calculated based on Revenues of 246.339 Cr
[ TTM - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
217645% NA (-ve EV) - |
SHARE PRICE MOMENTUM OF NURECA
NURECA vs SENSEX
DEBT OF NURECA
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2021 2020 2019 Avg_3yrs |
0.02 0.69 0 0.24 |
0.02 0.7 0.06 0.26 |
[Last Annual Data : Mar2021]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF NURECA
Pledged Promoter Shares |
NA | |
---|---|---|
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF NURECA
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
2.42% -15.15% -18.01% -12.88% |
-19.16% -35.94% -25.55% -24.89% |
QtrlyTrend |
-6 | |
Latest Qtr: Dec2021 | ||
Quarterly Result Analysis → |
NURECA related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE ALLCAP | -2.5% | -9% | 7.1% |
S&P BSE HEALTHCARE | -3.1% | -10.6% | -9.5% |
S&P BSE MIDSMALLCAP | -4.3% | -13% | 6.1% |
S&P BSE SMALL CAP | -4.9% | -14.1% | 9.3% |
You may also like the below Video Courses
FAQ about NURECA
Is NURECA good for long term investment?
As on May 25,2022, the Fundamentals of NURECA look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of NURECA . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is NURECA UnderValued or OverValued?
As on May 25,2022, NURECA is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of NURECA ?
As on May 25,2022, the Intrinsic Value of NURECA is Rs. 0.47 determined based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 0.47
Fair Value [Median EV / Sales Model] : Rs. -0.04
Fair Value [Median Price / Sales Model] : Rs. 0.00
Median Fair Value of NURECA : Rs. 0.47
Is NURECA trading at a Premium or Discount?
As on May 25,2022, NURECA is trading at a Premium of 216774% based on the estimates of Median Intrinsic Value!ADANI TRANSMISSION LTD vs ADANI ENTERPRISES LTD vs SUNDRAM FASTENERS LTD
REDINGTON (INDIA) LTD vs MMTC LTD vs NOVARTIS INDIA LTD
MSTC LTD vs SVP GLOBAL VENTURES LTD vs OPTIEMUS INFRACOM LTD
NURECA LTD vs FUTURE CONSUMER LTD vs MISHTANN FOODS LTD
HEXA TRADEX LTD vs INDIA MOTOR PARTS & ACCESSORIES LTD vs BLACK ROSE INDUSTRIES LTD
